T. Rowe Price Associates’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $6K | Hold |
|
|||||
|
2024
Q4 | $17K | Hold |
|
|||||
|
2024
Q3 | $21K | Hold |
|
|||||
|
2024
Q2 | $14K | Hold |
|
|||||
|
2024
Q1 | $54K | Buy |
|
|||||
|
2023
Q4 | $46K | Buy |
|
|||||
|
2023
Q3 | $52K | Buy |
|
|||||
|
2023
Q2 | $40K | Sell |
|
|||||
|
2023
Q1 | $71K | Hold |
|
|||||
|
2022
Q4 | $51K | Hold |
|
|||||
|
2022
Q3 | $51K | Sell |
|
|||||
|
2022
Q2 | $67K | Sell |
|
|||||
|
2022
Q1 | $119K | Hold |
|
|||||
|
2021
Q4 | $122K | Hold |
|
|||||
|
2021
Q3 | $128K | Hold |
|
|||||
|
2021
Q2 | $148K | Buy |
|
|||||
|
2021
Q1 | $148K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.44M | Sell |
|
|||||
|
2018
Q1 | $2.12M | Buy |
|
|||||
|
2017
Q4 | $2.96M | Sell |
|
|||||
|
2017
Q3 | $2.97M | Hold |
|
|||||
|
2017
Q2 | $3.64M | Buy |
|